Guggenheim Capital LLC grew its stake in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 45.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,533 shares of the medical device company’s stock after purchasing an additional 1,105 shares during the quarter. Guggenheim Capital LLC’s holdings in Cooper Companies were worth $932,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the stock. Kentucky Retirement Systems raised its stake in Cooper Companies by 16.5% during the 2nd quarter. Kentucky Retirement Systems now owns 3,659 shares of the medical device company’s stock worth $1,146,000 after buying an additional 517 shares during the period. Kentucky Retirement Systems Insurance Trust Fund grew its holdings in shares of Cooper Companies by 15.7% in the 2nd quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 1,684 shares of the medical device company’s stock valued at $527,000 after acquiring an additional 229 shares in the last quarter. United Capital Financial Advisers LLC grew its holdings in shares of Cooper Companies by 10.5% in the 2nd quarter. United Capital Financial Advisers LLC now owns 1,007 shares of the medical device company’s stock valued at $315,000 after acquiring an additional 96 shares in the last quarter. Prudential PLC grew its holdings in shares of Cooper Companies by 17.7% in the 3rd quarter. Prudential PLC now owns 1,271 shares of the medical device company’s stock valued at $335,000 after acquiring an additional 191 shares in the last quarter. Finally, Jennison Associates LLC grew its holdings in shares of Cooper Companies by 89.0% in the 3rd quarter. Jennison Associates LLC now owns 171,800 shares of the medical device company’s stock valued at $45,338,000 after acquiring an additional 80,893 shares in the last quarter. Institutional investors and hedge funds own 96.78% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on COO. JPMorgan Chase & Co. raised their price objective on Cooper Companies from $300.00 to $330.00 in a report on Monday, November 28th. Mizuho lifted their price target on Cooper Companies from $385.00 to $390.00 in a report on Friday, March 3rd. Piper Sandler lifted their price target on Cooper Companies from $350.00 to $375.00 and gave the stock an “overweight” rating in a report on Wednesday, January 11th. Robert W. Baird lifted their price target on Cooper Companies from $371.00 to $385.00 in a report on Friday, March 3rd. Finally, Citigroup lifted their price target on Cooper Companies from $348.00 to $368.00 and gave the stock a “buy” rating in a report on Monday, December 12th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $382.60.
Insider Buying and Selling at Cooper Companies
Cooper Companies Stock Down 2.8 %
NYSE COO opened at $336.34 on Wednesday. The company has a current ratio of 1.72, a quick ratio of 1.00 and a debt-to-equity ratio of 0.36. The Cooper Companies, Inc. has a 1-year low of $244.21 and a 1-year high of $429.89. The company has a 50 day moving average of $341.80 and a 200-day moving average of $310.67. The company has a market cap of $16.62 billion, a price-to-earnings ratio of 44.55, a PEG ratio of 2.52 and a beta of 0.89.
Cooper Companies (NYSE:COO – Get Rating) last released its quarterly earnings results on Thursday, March 2nd. The medical device company reported $2.90 earnings per share for the quarter, beating analysts’ consensus estimates of $2.66 by $0.24. Cooper Companies had a net margin of 11.10% and a return on equity of 8.39%. The company had revenue of $858.50 million during the quarter, compared to the consensus estimate of $834.90 million. During the same period in the previous year, the business earned $3.24 earnings per share. The firm’s quarterly revenue was up 9.1% on a year-over-year basis. On average, equities research analysts expect that The Cooper Companies, Inc. will post 12.67 earnings per share for the current fiscal year.
Cooper Companies Announces Dividend
The company also recently disclosed a Semi-Annual dividend, which was paid on Friday, February 10th. Shareholders of record on Monday, January 23rd were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, January 20th. Cooper Companies’s dividend payout ratio is currently 0.79%.
About Cooper Companies
The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.
- Get a free copy of the StockNews.com research report on Cooper Companies (COO)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets “Powelled”: S&P 500 Confirms Resistance
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Rivian Plummets, But Is This 2023’s Greatest Buying Opportunity?
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COO – Get Rating).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.